Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion

Mariuxi C. Manukyan, Andrew C. Keck, Jeffrey A. Poynter, Yue Wang, Brent R. Weil, Aaron M. Abarbanell, Jeremy L. Herrmann, Brandon J. Crowe, Collin Alvernaz, Daniel R. Meldrum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The activation of the epidermal growth factor family of receptors may improve cardiac protection after injury. One epidermal growth factor family ligand, transforming growth factor-alpha, promotes wound healing in multiple tissues in response to oxidative injury and might confer resistance to myocardial depressant factors, although the role of transforming growth factor-alpha in myocardial ischemia/reperfusion injury is unknown. We hypothesized that preischemic infusion of transforming growth factor-alpha would improve myocardial functional recovery after acute ischemia/reperfusion. Methods: The hearts from adult male rats were isolated and perfused via the Langendorff model. Immediately prior to ischemia, the hearts received an intracoronary infusion of either vehicle or transforming growth factor-alpha (1 ng, 10 ng, or 100 ng). After reperfusion, the hearts were assessed for activation of the prosurvival pathway, Akt. Results: Infusion of transforming growth factor-alpha did not confer any additional functional protection compared with the vehicle, but myocardial tissue analysis revealed significantly increased activation of the Akt pathway in both the 10-ng and 100-ng groups. Conclusion: Preischemic infusion of transforming growth factor-alpha does not improve myocardial functional recovery after ischemia/reperfusion injury. Whereas transforming growth factor-alpha treatment does affect actions at the molecular level, these actions do not translate into an observable functional effect. This lack of improvement may point to a relative unimportance of transforming growth factor-alpha in myocardial signaling compared with other epidermal growth factor ligands.

Original languageEnglish
Pages (from-to)339-346
Number of pages8
JournalSurgery
Volume150
Issue number2
DOIs
StatePublished - Aug 2011

Fingerprint

Transforming Growth Factor alpha
Reperfusion
Myocardium
Ischemia
Reperfusion Injury
Epidermal Growth Factor
Myocardial Depressant Factor
Ligands
Myocardial Reperfusion Injury
Wounds and Injuries
Wound Healing
Myocardial Ischemia

ASJC Scopus subject areas

  • Surgery

Cite this

Manukyan, M. C., Keck, A. C., Poynter, J. A., Wang, Y., Weil, B. R., Abarbanell, A. M., ... Meldrum, D. R. (2011). Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion. Surgery, 150(2), 339-346. https://doi.org/10.1016/j.surg.2011.05.018

Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion. / Manukyan, Mariuxi C.; Keck, Andrew C.; Poynter, Jeffrey A.; Wang, Yue; Weil, Brent R.; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Crowe, Brandon J.; Alvernaz, Collin; Meldrum, Daniel R.

In: Surgery, Vol. 150, No. 2, 08.2011, p. 339-346.

Research output: Contribution to journalArticle

Manukyan, MC, Keck, AC, Poynter, JA, Wang, Y, Weil, BR, Abarbanell, AM, Herrmann, JL, Crowe, BJ, Alvernaz, C & Meldrum, DR 2011, 'Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion', Surgery, vol. 150, no. 2, pp. 339-346. https://doi.org/10.1016/j.surg.2011.05.018
Manukyan, Mariuxi C. ; Keck, Andrew C. ; Poynter, Jeffrey A. ; Wang, Yue ; Weil, Brent R. ; Abarbanell, Aaron M. ; Herrmann, Jeremy L. ; Crowe, Brandon J. ; Alvernaz, Collin ; Meldrum, Daniel R. / Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion. In: Surgery. 2011 ; Vol. 150, No. 2. pp. 339-346.
@article{561790aa5b5047ceb9aef7419a7c44c0,
title = "Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion",
abstract = "Background: The activation of the epidermal growth factor family of receptors may improve cardiac protection after injury. One epidermal growth factor family ligand, transforming growth factor-alpha, promotes wound healing in multiple tissues in response to oxidative injury and might confer resistance to myocardial depressant factors, although the role of transforming growth factor-alpha in myocardial ischemia/reperfusion injury is unknown. We hypothesized that preischemic infusion of transforming growth factor-alpha would improve myocardial functional recovery after acute ischemia/reperfusion. Methods: The hearts from adult male rats were isolated and perfused via the Langendorff model. Immediately prior to ischemia, the hearts received an intracoronary infusion of either vehicle or transforming growth factor-alpha (1 ng, 10 ng, or 100 ng). After reperfusion, the hearts were assessed for activation of the prosurvival pathway, Akt. Results: Infusion of transforming growth factor-alpha did not confer any additional functional protection compared with the vehicle, but myocardial tissue analysis revealed significantly increased activation of the Akt pathway in both the 10-ng and 100-ng groups. Conclusion: Preischemic infusion of transforming growth factor-alpha does not improve myocardial functional recovery after ischemia/reperfusion injury. Whereas transforming growth factor-alpha treatment does affect actions at the molecular level, these actions do not translate into an observable functional effect. This lack of improvement may point to a relative unimportance of transforming growth factor-alpha in myocardial signaling compared with other epidermal growth factor ligands.",
author = "Manukyan, {Mariuxi C.} and Keck, {Andrew C.} and Poynter, {Jeffrey A.} and Yue Wang and Weil, {Brent R.} and Abarbanell, {Aaron M.} and Herrmann, {Jeremy L.} and Crowe, {Brandon J.} and Collin Alvernaz and Meldrum, {Daniel R.}",
year = "2011",
month = "8",
doi = "10.1016/j.surg.2011.05.018",
language = "English",
volume = "150",
pages = "339--346",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion

AU - Manukyan, Mariuxi C.

AU - Keck, Andrew C.

AU - Poynter, Jeffrey A.

AU - Wang, Yue

AU - Weil, Brent R.

AU - Abarbanell, Aaron M.

AU - Herrmann, Jeremy L.

AU - Crowe, Brandon J.

AU - Alvernaz, Collin

AU - Meldrum, Daniel R.

PY - 2011/8

Y1 - 2011/8

N2 - Background: The activation of the epidermal growth factor family of receptors may improve cardiac protection after injury. One epidermal growth factor family ligand, transforming growth factor-alpha, promotes wound healing in multiple tissues in response to oxidative injury and might confer resistance to myocardial depressant factors, although the role of transforming growth factor-alpha in myocardial ischemia/reperfusion injury is unknown. We hypothesized that preischemic infusion of transforming growth factor-alpha would improve myocardial functional recovery after acute ischemia/reperfusion. Methods: The hearts from adult male rats were isolated and perfused via the Langendorff model. Immediately prior to ischemia, the hearts received an intracoronary infusion of either vehicle or transforming growth factor-alpha (1 ng, 10 ng, or 100 ng). After reperfusion, the hearts were assessed for activation of the prosurvival pathway, Akt. Results: Infusion of transforming growth factor-alpha did not confer any additional functional protection compared with the vehicle, but myocardial tissue analysis revealed significantly increased activation of the Akt pathway in both the 10-ng and 100-ng groups. Conclusion: Preischemic infusion of transforming growth factor-alpha does not improve myocardial functional recovery after ischemia/reperfusion injury. Whereas transforming growth factor-alpha treatment does affect actions at the molecular level, these actions do not translate into an observable functional effect. This lack of improvement may point to a relative unimportance of transforming growth factor-alpha in myocardial signaling compared with other epidermal growth factor ligands.

AB - Background: The activation of the epidermal growth factor family of receptors may improve cardiac protection after injury. One epidermal growth factor family ligand, transforming growth factor-alpha, promotes wound healing in multiple tissues in response to oxidative injury and might confer resistance to myocardial depressant factors, although the role of transforming growth factor-alpha in myocardial ischemia/reperfusion injury is unknown. We hypothesized that preischemic infusion of transforming growth factor-alpha would improve myocardial functional recovery after acute ischemia/reperfusion. Methods: The hearts from adult male rats were isolated and perfused via the Langendorff model. Immediately prior to ischemia, the hearts received an intracoronary infusion of either vehicle or transforming growth factor-alpha (1 ng, 10 ng, or 100 ng). After reperfusion, the hearts were assessed for activation of the prosurvival pathway, Akt. Results: Infusion of transforming growth factor-alpha did not confer any additional functional protection compared with the vehicle, but myocardial tissue analysis revealed significantly increased activation of the Akt pathway in both the 10-ng and 100-ng groups. Conclusion: Preischemic infusion of transforming growth factor-alpha does not improve myocardial functional recovery after ischemia/reperfusion injury. Whereas transforming growth factor-alpha treatment does affect actions at the molecular level, these actions do not translate into an observable functional effect. This lack of improvement may point to a relative unimportance of transforming growth factor-alpha in myocardial signaling compared with other epidermal growth factor ligands.

UR - http://www.scopus.com/inward/record.url?scp=79960923465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960923465&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2011.05.018

DO - 10.1016/j.surg.2011.05.018

M3 - Article

VL - 150

SP - 339

EP - 346

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -